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Introduction
Removal of introns from primary RNA transcripts (splicing) 
takes place in specialized complexes called spliceosomes, in 
which factors needed for splicing of pre-mRNAs are enriched. 
Currently,  >150 different proteins and several small RNAs 
have been identifi  ed as part of spliceosomes, which are organized 
in distinct subcomplexes. The most prominent spliceosome 
subunits are the uridine-rich small nuclear RNPs (U snRNPs) 
of the Sm class. They consist of an RNA component (uridine-
rich small nuclear RNA [U snRNA]) and numerous proteins 
that are either common for all or specifi  c for one particle (for 
review see Nilsen, 2003).
Even though splicing occurs in the nucleus, major parts 
of the biogenesis of U snRNPs take place in the cytoplasm. 
The nuclear-encoded m
7G-capped U snRNA is transiently ex-
ported to the cytoplasm to allow binding of the common (Sm) 
proteins. This leads to the formation of the Sm core domain, the 
structural framework of all spliceosomal U snRNPs of the Sm 
class (Raker et al., 1996). Formation of the Sm core is required 
for cap hypermethylation and the subsequent nuclear import of 
U snRNPs (Hamm et al., 1990). Within the nucleus, U snRNPs 
are fi  rst targeted to subnuclear domains termed Cajal bodies 
(CBs), where additional modifi  cations on the RNA occur and at 
least some specifi  c proteins are added. Eventually, the mature 
U snRNPs migrate to perichromatin fi  brils, the sites of transcrip-
tion and splicing (for reviews see Meister et al., 2002; Matera 
et al., 2007).
Interestingly, recent studies indicated that several aspects 
of the biogenesis cycle of U snRNPs are factor mediated and 
regulated in vivo. The most prominent factor in this process is 
the survival motor neuron (SMN) complex, a macromolecular 
entity that actively mediates the binding of the common Sm 
proteins onto U snRNAs. This complex consists of nine major 
proteins, including the SMN gene product, Gemin2–8, and the unr-
interacting protein (unrip; for reviews see Meister et al., 2002; 
Gubitz et al., 2004; Pellizzoni, 2007) (Carissimi et al., 2005; 
Grimmler et al., 2005b). The SMN complex is controlled by 
another complex, whose name-giving component is the type-II 
protein arginine methyltransferase 5. This unit, possibly in 
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pattern of SMN and Gemin3, loss of SMN from CBs, and 
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of inactive, PPM1G. This demonstrates that PPM1G’s 
phosphatase activity is necessary to maintain SMN sub-
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acting protein (unrip), a component implicated in cytoplasmic 
retention of the SMN complex, also rescues the localiza-
tion defects. Our data suggest that an interplay between 
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SMN complex.
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conjunction with other factors, converts arginine residues in 
some Sm proteins into symmetrical dimethylarginines, thereby 
enhancing their affi  nity for the SMN complex and stimulating 
U snRNP assembly (Brahms et al., 2001; Friesen et al., 2001; 
Meister et al., 2001b; Meister and Fischer, 2002). Furthermore, 
it has been shown that the SMN complex (or parts thereof) also 
participate in the subsequent nuclear import of U snRNPs 
(Narayanan et al., 2004; Shpargel and Matera, 2005). Once in the 
nucleus, both units migrate to CBs, where the SMN complex 
accumulates and U snRNPs are released to sites of splicing after 
additional maturation steps (Stanek and Neugebauer, 2006). 
These observations suggest that U snRNPs dissociate from 
SMN complexes in CBs and that the SMN complex returns as a 
separate unit to the cytoplasm at later stages.
Although the cytoplasmic role of the SMN complex is 
understood in some detail, its functions in the nucleus are only 
poorly characterized. Thus, it is still unclear how U snRNPs 
are separated from the SMN complex after nuclear import and 
how the return of the SMN complex to the cytoplasm is facili-
tated. An important player in this process might be unrip, which 
interacts with the SMN complex primarily in the cytoplasm. 
Knockdown of this factor leads to enhanced accumulation of 
SMN in nuclear bodies (Grimmler et al., 2005b), suggesting a 
role of unrip in the intracellular distribution of the SMN complex. 
The biogenesis of U snRNPs appears also to be infl  uenced by 
phosphorylation of different components of the assembly 
machinery. Thus, it has been shown that SMN is highly phos-
phorylated when it is in the cytoplasm, whereas the nuclear pool 
is hypophosphorylated (Grimmler et al., 2005a). Compartment-
specifi  c determinants and the phosphorylation status of SMN 
(and potentially other SMN-complex components) could hence 
infl  uence the biogenesis pathway of U snRNPs in the cytoplasm 
and in the nucleus.
Here, we show that the SMN complex specifi  cally inter-
acts with the nuclear phosphatase PPM1G/PP2Cγ (here referred 
to as PPM1G). This C-type, Mg
2+/Mn
2+-dependent phosphatase 
has previously been shown to be specifi  cally involved in nuclear 
functions, including splicing (Murray et al., 1999; Allemand 
et al., 2007) and nucleosome assembly (Kimura et al., 2006). 
Knockdown of PPM1G led to reduced dephosphorylation 
of SMN-complex proteins and abolished accumulation of SMN 
proteins in CBs. Rescue experiments demonstrate that the catalytic 
activity of the phosphatase is necessary to maintain the specifi  c 
localization of the SMN proteins in the nucleus. Our data support 
the idea that PPM1G is a major regulator of nuclear functions of 
the SMN complex: it determines the SMN complex’s compart-
ment-specifi  c phosphorylation pattern and is required for its 
correct localization and stability.
Results
PPM1G is a nuclear phosphatase 
in vertebrates
As published recently, the compartment-specifi  c phosphoryla-
tion pattern of the SMN protein pointed to the activity of a nu-
clear phosphatase, which dephosphorylates proteins of the SMN 
complex (Grimmler et al., 2005a). One potential candidate that 
may govern SMN modifi  cations in the nucleus is PPM1G, 
which has been suggested to localize to the nucleus and to func-
tion in splicing (Murray et al., 1999). Consistent with this, anti-
bodies generated against the human (Fig. 1 A) or the Xenopus 
laevis orthologue of PPM1G (xPPM1G; Fig. 1 B) detected this 
protein in the nucleoplasm in both human HeLa and X. laevis 
XL177 cells when used for indirect immunofl  uorescence (Fig. 
1 C). Sequence analysis revealed two stretches of basic amino 
acids in the C terminus of human PPM1G (hPPM1G), which 
could serve as an NLS. The region of the potential C-terminal 
NLS is conserved throughout most vertebrates (Fig. 1 E). Indeed, 
when we expressed the full-length or a truncated version of 
hPPM1G lacking the C-terminal NLS as EYFP fusions in 
human HeLa cells, only the full-length protein showed nuclear 
accumulation, whereas the truncated version did not (Fig. 1 D). 
Likewise, accumulation of fl  uorescently labeled xPPM1G in 
in vitro reconstituted nuclei was not seen for analogous C-terminal 
truncations of xPPM1G, although the truncation did not affect 
the catalytic activity of xPPM1G (unpublished data). Moreover, 
when we manually dissected X. laevis oocytes into cytosolic 
and nuclear fractions, we exclusively detected xPPM1G in the 
nuclear fraction using our xPPM1G antibody (Fig. 1 B). Using 
quantitative immunoblotting, we estimated the abundance of 
PPM1G in X. laevis oocyte nuclei to be in the range of 5 μM 
and at least 1 μM in HeLa cell nuclei, which is consistent with 
recently published data (Kimura et al., 2006). This shows that 
PPM1G is an abundant nuclear phosphatase in vertebrates.
Interaction of PPM1G with the SMN 
complex
To address whether PPM1G might regulate nuclear functions 
of the SMN complex, we tested if PPM1G was directly associ-
ated with the SMN complex. We affi  nity-purifi  ed SMN-complex 
proteins from total cellular extracts using a monoclonal anti-
body directed against the N terminus of human SMN. Bound 
proteins were eluted and compared with an eluate of a con-
trol column by SDS-PAGE and silver staining. Known SMN-
  complex components (i.e., SMN, Gemin3–5, and unrip) were 
eluted from this column as determined by mass spectrometry 
and/or Western blotting (Fig. 2 A, compare lanes 2 and 3). 
Moreover, among the proteins coeluting with the SMN complex 
in the 70-kD range was the protein phosphatase PPM1G, which 
we identifi  ed on the basis of 21 peptides covering 32.9% of its 
sequence (not depicted). Immunoblot analysis with antibodies 
against hPPM1G confi  rmed that PPM1G specifi  cally bound to 
the SMN complex but not to the control column (Fig. 2 B, com-
pare lanes 2 and 3).
To further analyze binding of PPM1G to the SMN com-
plex, we affi  nity purifi  ed the SMN complex, as described in the 
previous paragraph, and incubated the complex with recombi-
nant His-tagged human wild-type (wt) PPM1G (rec.hPPM1Gwt). 
In parallel, we generated a mutant PPM1G (rec.PPM1Gmut) in 
which aa 496 was changed from an aspartate into an alanine 
(Murray et al., 1999). The recombinant mutant protein showed 
dramatically reduced catalytic activity (unpublished data). After 
incubation and removal of unbound proteins by extensive wash-
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Figure 1.  Nuclear localization of protein phosphatase PPM1G is conserved among vertebrates. (A) Immunoblot testing afﬁ  nity-puriﬁ  ed antibody raised 
against hPPM1G on total HeLa lysate. (B) Immunoblot testing antibodies against xPPM1G and determining the subcellular localization of PPM1G in X. laevis 
oocytes. 1 and 2 represent two different pools of nuclei (nuc) and corresponding cytosols (cyt) from manually dissected stage VI oocytes. a and b represent 
two different pools of complete lysates from stage VI oocytes. (C) Indirect immunoﬂ  uorescence on HeLa cells using the antibodies against hPPM1G (top) 
or on XL177 cells using the antibody against xPPM1G (bottom). Bars, 20 μm. (D) Immunoﬂ  uorescence on HeLa cells being transfected with monomeric 
pEYFP-C1 vectors encoding either full-length (EYFP-hPPM1G) or hPPM1G without the NLS (EYFP-hPPM1G-NLS). Cells were ﬁ  xed 40 h after transfection and 
stained with an antibody against GFP. Bars, 40 μm. (E) C termini of PPM1G from four different vertebrate species were aligned using MegAlign software 
(DNA Star); conserved residues are highlighted in yellow; the glutamate residue critical for phosphatase activity (D496 in hPPM1G) is indicated in blue; 
and predicted NLS sequences (P-sort software; www.psort.org) are indicated in red. Sequences used are the following: Homo sapiens, O15355; Mus 
musculus, Q61074; X. laevis, Q7ZYR7; and Gallus gallus (nucleotides 173–1859 from GenBank/EMBL/DDBJ under accession no. XR_026917) after an 
additional nucleotide (G) had been inserted in position 1675 (see ChEST73b8, ChEST376n8, and others from BBSRC ChickEST Database). JCB • VOLUME 179 • NUMBER 3 • 2007  454
SDS-PAGE and silver staining (Fig. 2 C) and immunoblotting 
(Fig. 2 D). Detection of the SMN protein verifi  ed the specifi  city 
of the purifi  cation (Fig. 2,  C and D [bottom]; note that SMN 
could only be detected upon immunopurifi  cation with the 
specifi  c antibodies [IP SMN] but not in controls [IP control]). 
PPM1Gwt and catalytically inactive PPM1G were equally de-
tectable in the bound fraction of purifi  ed SMN complexes but 
not in controls (Fig. 2, C and D [top]). Although the wt protein 
actively dephosphorylated the SMN protein, as indicated by a 
slightly changed mobility of SMN (Fig. 2, C [SMN] and D 
[bottom]), interaction of either wt or catalytically inactive PPM1G 
with the SMN complex was equally effi  cient but did not change 
the overall composition of the complex as judged by silver 
staining of immunocomplexes and immunoblot detection of
SMN and unrip (Fig. 2, C and D). Collectively, these data 
identify the nuclear phosphatase PPM1G as a novel interaction 
partner of the SMN complex.
PPM1G is required for proper localization 
of the SMN complex in CBs
We next asked whether PPM1G was required for proper local-
ization of the SMN complex. Based on immunofl  uorescence 
experiments, it had been reported that SMN is diffusely dis-
tributed in the cytoplasm but localized in the nucleus, where it 
is found to be highly enriched in specifi  c bodies termed gems 
(Liu and Dreyfuss, 1996). However, later studies showed that 
these bodies are in most, but not all, cell lines equivalent to the 
well-known nuclear CBs (Carvalho et al., 1999; Dundr et al., 
2004). In agreement with previous data, we observed strong 
accumulation of SMN in CBs of HeLa CCL2 cells (unpublished 
data). To analyze the role of PPM1G in the localization of SMN 
proteins, we knocked down PPM1G expression in HeLa CCL-2 
cells by RNA interference using three different synthetic double-
stranded siRNA oligonucleotides. As judged by immunoblotting, 
all three siRNAs effi  ciently reduced the protein amount of PPM1G 
(Fig. 3 A; the knockdown effi  ciency was typically 75–95%). Oligo 
pairs #1 and #3, however, were reproducibly the most effi  cient 
and therefore were used for further phenotypic analysis (Fig. 3 A). 
When SMN-complex localization was tested in siRNA-treated 
cells, we observed substantial reduction of the nuclear PPM1G 
in the majority of treated cells (Fig. 3 B). This was correlated 
with SMN disappearing from CBs (Fig. 3, B and D). Likewise 
Gemin2, a direct interaction partner of SMN, disappeared from 
CBs upon PPM1G knockdown (Fig. 3 C). Concomitantly, in 
Figure 2.  Interaction of PPM1G and the SMN 
complex. (A) SMN complex was precipitated 
from HeLa cell extract with a monoclonal anti-
SMN antibody (7B10), covalently linked to 
protein G–Sepharose (IP-SMN). An unrelated 
mouse serum, covalently linked to protein G–
Sepharose, was used as control (IP control). 
Interacting proteins were eluted by boiling in 
2× SDS sample buffer, separated by SDS-PAGE, 
and analyzed by silver staining. (B) Immuno-
precipitations of SMN complex (lane 3) or 
controls (lane 2) were done as described in A 
and analyzed by immunoblotting using spe-
ciﬁ  c SMN or PPM1G antibodies, respectively. 
Lane 1 shows HeLa cell total extract. (C) Inter-
action of recombinant PPM1G with the SMN 
complex. Immunoprecipitated SMN complex 
(lanes 2 and 3) or controls (lanes 4 and 5) 
were incubated with 5 μg of 6× histidine-
tagged, puriﬁ  ed, recombinant PPM1Gwt (rec.
PPM1Gwt; lanes 2 and 4) or catalytically inac-
tive PPM1G (D496A, rec.PPM1Gmut; lanes 3 
and 5). Bound proteins were eluted by boiling 
in 2× SDS sample buffer, resolved by SDS-
PAGE, and analyzed by silver staining. (D) Sam-
ples generated as described in C were analyzed 
by immunoblotting using anti-histidine (top), anti-
  unrip (middle), or anti-SMN antibodies (bottom). 
Note that because of different gels and mark-
ers used in B–D, the apparent molecular mass 
of PPM1G is slightly different in these panels.SMN ACCUMULATION IN CBS IS GOVERNED BY PPM1G • PETRI ET AL. 455
 50% of all cells the diffuse nucleoplasmic signal of SMN or 
Gemin2 was increased (Fig. 3, B and C), whereas low nucleo-
plasmic SMN signals were observed in other cells (Fig. 3, B–D; 
and Fig. 4). Similarly, upon overexpression of  PPM1G lacking 
the C-terminal NLS (Fig. 1) we frequently observed reduced cyto-
plasmic and increased diffuse nuclear staining of SMN. However, 
accumulation of SMN in CBs was not affected (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200704163/DC1). 
Figure 3.  siRNA-mediated knockdown of PPM1G from HeLa cells induces the loss of SMN complex from CBs. (A) Representative experiment showing the 
depletion efﬁ  ciency of the three siRNA oligonucleotides (#1, #2, and #3) against PPM1G mRNA. An oligonucleotide against vimentin mRNA was used as 
a control (c). (top) Immunoblot detection of PPM1G levels 60 h after transfection of cells. Total protein was analyzed by Immunoblotting with antibodies as 
indicated (snurportin1 [SnpI], loading control). (bottom) Quantiﬁ  cation of relative PPM1G amounts from the Immunoblot shown on top. (B) Immuno-
ﬂ  uorescence staining of HeLa cells after control treatment or knockdown of PPM1G (∆PPM1G, shown here and in C after treatment with oligo #1; the same 
phenotype was observed with oligo #3). Cells were ﬁ  xed 60 h after transfection with siRNA oligonucleotides and stained for SMN and PPM1G. (C) Knock-
down of PPM1G as in B. Cells were stained for SMN and Gemin2. Asterisks show cells with increased nucleoplasmic SMN signal. (D) Quantiﬁ  cation of 
cells showing loss of SMN staining in CBs (phenotypes after treatment with oligo #1 or #3). Bars represent the relative number of cells showing localized 
SMN staining in the nucleus after PPM1G knockdown. Relative numbers are given as means from three independent experiments and error bars represent SD. 
Absolute numbers of counted cells were as follows (1/2/3 experiment): control, 134/163/172; oligo #1, 99/204/149; and oligo #3, 104/236/158. 
(E) PPM1G knockdown and SMN delocalization are correlated on the single cell level. HeLa cells were transfected with control or PPM1G #1 siRNA oligo-
nucleotides separately, mixed 15 h after transfection, and plated out together on coverslips. 80 h after transfection, cells were ﬁ  xed and immunostained for 
SMN and PPM1G. Bars, 20 μm.JCB • VOLUME 179 • NUMBER 3 • 2007  456
Collectively, these data suggest that nuclear PPM1G is required 
for correct nuclear-  cytoplasmic distribution and subcellular 
localization of the SMN complex.
To confi  rm correlation of the effi  ciency of PPM1G knock-
down and the loss of the localized nuclear SMN signal, we trans-
fected cells with control siRNA oligos or siRNA oligos to 
knockdown PPM1G and mixed them after transfection. Indeed, 
when residual staining of PPM1G was hardly detectable, no ac-
cumulation of SMN in nuclear bodies was observed. In contrast, 
PPM1G was still clearly detectable in cells, which regularly 
showed normal SMN staining in the nucleus (Fig. 3 E).
Accumulation of SMN in CBs depends on the interaction 
of SMN with coilin (Hebert et al., 2001, 2002), one of the central 
molecular components of CBs (Stanek and Neugebauer, 2006). 
We therefore determined whether down-regulation of PPM1G 
affected coilin localization. Knockdown of PPM1G frequently 
resulted in the accumulation of additional small   coilin-positive 
structures (Fig. 4, A and B). However, coilin still strongly accu-
mulated in CBs upon PPM1G knockdown (Fig. 4, A and B). 
Importantly, this was observed in cells in which loss of SMN 
from CBs was verifi  ed by direct SMN detection (Fig. 4 B). 
Collectively, these data suggest that PPM1G is required for the 
  accumulation of SMN and Gemin2 in CBs but is not a major 
determinant of overall CB integrity as judged by coilin staining.
PPM1G inﬂ  uences the stability 
and thus the function of the SMN 
complex but does not change 
the pattern of spliceosome speckles
In the course of our experiments, we noted that the expression 
levels of SMN and Gemin2 were reduced upon knockdown of 
PPM1G, which is consistent with a destabilization of SMN-
complex proteins. We therefore determined the amounts of dif-
ferent SMN proteins by quantitative immunoblotting after 
PPM1G knockdown with the two most effective oligo pairs. When 
PPM1G was depleted by  90%, the levels of SMN, Gemin2, 
and Gemin3 were also considerably reduced. This effect was 
specifi  c, as the level of the nonrelated protein regulator of 
Figure 4.  Knockdown of PPM1G from HeLa cells does not compromise coilin accumulation in CBs. Immunoﬂ  uorescence staining of HeLa cells after control 
treatment or knockdown of PPM1G (∆PPM1G, oligo #1; the same phenotype was seen with oligo #3). Cells were ﬁ  xed 60 h after transfection with siRNA 
oligonucleotides and stained for coilin and PPM1G (A) or coilin and SMN (B). Bars, 20 μm.SMN ACCUMULATION IN CBS IS GOVERNED BY PPM1G • PETRI ET AL. 457
chromosome condensation 1 (RCC1) was not affected (Fig. 5, 
A and B). To determine where SMN was primarily destabilized, 
we knocked down PPM1G (Fig. 5 C, left), fractionated the cells, 
and determined amounts of SMN-complex proteins in the 
nuclear and cytosolic fractions by immunoblotting. Although 
levels of both Gemin2 and SMN were reduced in both fractions, 
protein loss was more pronounced in nuclear fractions. Interest-
ingly, levels of the cytoplasmic interaction partner of the SMN-
complex unrip were not substantially changed (Fig. 5 C, right). 
When we followed the knockdown of PPM1G and the destabi-
lization of SMN proteins over time, we observed that PPM1G 
preceded the depletion of SMN and Gemin2, suggesting that its 
Figure 5.  The SMN complex is destabilized upon PPM1G knockdown in HeLa cells. (A) Immunoblot detection of PPM1G, Gemin2, and Gemin3 60 h after 
transfection of HeLa cells with siRNA oligonucleotides #1 or #3 against PPM1G. Total protein from HeLa cells was analyzed by immunoblotting with anti-
bodies as indicated. RCC1 detection was used as a loading control. (B) Quantiﬁ  cation of relative protein amounts after PPM1G knockdown in HeLa cells 
as shown in A. Relative amounts of PPM1G, SMN, and Gemin2 were averaged from three independent experiments. Amounts of Gemin3 were quantiﬁ  ed 
from the experiment shown in A. Error bars represent SD. (C) Reduction of SMN and Gemin2 in the cytoplasm and in the nucleus after siRNA-mediated 
knockdown of PPM1G. Control-treated (c) and PPM1G siRNAi-treated (∆P) HeLa cells were fractionized into cytosol, and nuclei and fractions were immuno-
blotted for components of the SMN complex (unrip, Gemin2, and SMN) and for RCC1 (only nuclear) as a control for proper separation. (D) Destabilization 
of SMN and Gemin2 follow the knockdown of PPM1G from HeLa cells. Total cell lysates were analyzed by immunoblotting for relative amounts of PPM1G, 
SMN, and Gemin2 at indicated times after transfection with siRNA oligonucleotide #3 against PPM1G. □, relative amounts of PPM1G; △, amounts of 
SMN; ○, amounts of Gemin2. Signals of proteins as analyzed 15 h after transfection were set to 100%. Amounts of the small GTPase Ran were analyzed 
and used to normalize quantiﬁ  cations of SMN and Gemin2 proteins. (E) U snRNP assembly activity of HeLa cytosolic extracts derived from control cells (c) 
or cells after knockdown of PPM1G (∆P). Extracts with equal amounts of total protein (left) or extracts normalized by immunoblotting to identical amounts 
of SMN protein (right) were assessed for U snRNP assembly by using 
32P-labeled U1 snRNA as previously described (Meister et al., 2001a) and quantiﬁ  ed. 
The activity of control extracts was set to 100%. Error bars represent SD from three independent experiments.JCB • VOLUME 179 • NUMBER 3 • 2007  458
knockdown is causative for the reduced amounts of SMN pro-
teins (Fig. 5 D). To determine whether decreased SMN levels led 
to impaired SMN function, we tested assembly of U1 snRNPs 
by band-shift experiments (Meister et al., 2001a). As expected, 
reduced snRNP assembly was observed upon PPM1G knock-
down (Fig. 5 E; 48.9 ± 10% compared with control extracts), 
but after normalizing SMN protein levels similar activities were 
again observed (Fig. 5 E, normalized SMN; 107 ± 29.4%), 
indicating that residual SMN complex after PPM1G knock-
down was equally functional to that in control lysates.
Previously published data describing a function of PPM1G 
in cell-free splicing assays (Murray et al., 1999) suggested an 
important role of PPM1G for the assembly of the complete spli-
ceosome machinery. Defects in the integrity of the splicing ma-
chinery led to dramatic changes in the characteristic speckle-like 
localization of the arginine/serine-rich splicing factor 2 (SC35) 
protein (O’Keefe et al., 1994), an integral component of splice-
osomes. Although PPM1G knockdown caused extensive or 
complete loss of the localized nuclear accumulation of Gemin2 
as a marker for the SMN complex (Fig. 6, b and c), no obvious 
change in the overall pattern of SC35 staining was observed. 
This suggests that the overall structure of the splicing machinery 
was not readily affected after knockdown of PPM1G, whereas 
Gemin2 was lost from CBs.
The catalytic activity of PPM1G promotes 
accumulation of SMN in CBs
A possible explanation for the loss of SMN proteins from CBs 
is that PPM1G directly dephosphorylates a protein of the SMN 
complex and that this dephosphorylation is instrumental for 
effi  cient targeting or accumulation of the SMN complex in CBs. 
This hypothesis assumes that the loss of the catalytic activity of 
PPM1G is responsible for the observed phenotype. To directly 
test whether the catalytic activity of PPM1G is required for the 
stability of the SMN complex in nuclear CBs, we used the mouse 
orthologue of the human cDNA to complement the siRNA-
induced phenotype. The mouse mRNA mismatches in two posi-
tions with the corresponding human mRNA, making it much less 
sensitive to the human siRNAs. Overexpression of the mouse 
HA-tagged wt protein upon transfection with siRNA oligos con-
s  iderably increased the number of cells showing the characteristic 
localization of the SMN complex in CBs compared with cells 
treated with the siRNA only (Fig. 7, A and B; and not depicted). 
To analyze whether the catalytic activity of PPM1G was essen-
tial for rescue activity, we generated a catalytically inactive 
mutant of mouse PPM1G (mPPM1G) in which aspartate in posi-
tion 493 was replaced by alanine (D493A) corresponding to 
the D496A mutant in hPPM1G (Murray et al., 1999; Fig. 1 E). 
Upon expression of the mutant protein, the number of cells 
showing SMN accumulation in CBs was not substantially 
different from the number in nonrescued controls (Fig. 7, A and B). 
This indicates that the catalytic activity of PPM1G promotes 
accumulation of the SMN complex in CBs and suggests that 
PPM1G is a major determinant of the SMN-complex local-
ization in the nucleus.
Reduction of PPM1G levels leads to 
impaired dephosphorylation of SMN 
and Gemin3
Given that phosphatase activity of PPM1G was required for 
SMN accumulation in CBs, we next analyzed the dephosphory-
lation of the major phosphoproteins of the SMN complex, SMN 
and Gemin3 (Grimmler et al., 2005a). We prepared control 
extracts, which had been incubated with immobilized unspecifi  c 
IgG, and extracts from which PPM1G was effi  ciently immuno-
depleted using immobilized anti-PPM1G antibodies (Fig. 8, 
A and B). To measure the effi  ciency of dephosphorylation of 
SMN-complex proteins, we fi  rst immunopurifi  ed the SMN 
complex and labeled SMN-complex proteins by the addition of 
γ-[
32P]ATP and a complete HeLa extract. Next, we compared 
the dephosphorylation of purifi  ed SMN-complex components 
in a chase reaction in extracts without ATP. Indeed, we observed 
considerably less effi  cient dephosphorylation upon depletion of 
PPM1G from extracts used for the dephosphorylation reaction 
(Fig. 8 A, compare ∆C and ∆P after 60 min). Moreover, the 
mobility of Gemin3 on SDS gels was reproducibly increased 
upon dephosphorylation in control extracts but not in PPM1G-
depleted extracts, whereas the mobility of Gemin4 remained 
unchanged (Fig. 8 A). This suggested that PPM1G dephosphory-
lated both SMN and Gemin3 in cell-free extracts. To confi  rm 
this result in living cells, we determined the phosphorylation 
pattern of SMN- complex proteins upon knockdown of PPM1G. 
PPM1G knockdown did not change the overall phosphorylation 
pattern of cellular proteins as judged by immunoblotting using 
total lysates and an antibody against phosphoserine/threonine 
epitopes (Fig. 8 C). To determine the phosphorylation states of 
Figure 6.  SMN delocalization from CBs induced by PPM1G depletion is not correlated with a change in SC35 localization. 72 h after knockdown of PPM1G, 
HeLa cells were ﬁ  xed and stained for Gemin2 and SC35. Cells showing pronounced localized nuclear Gemin2 staining (a), a strongly reduced localized 
nuclear Gemin2 staining (b), or no localized nuclear Gemin2 staining (c) did not show a considerably different SC35 staining pattern. Bar, 20 μm.SMN ACCUMULATION IN CBS IS GOVERNED BY PPM1G • PETRI ET AL. 459
Gemin3 and SMN, we separated total proteins from lysates of 
control cells or cells after PPM1G knockdown on conventional 
2D gels. Immunoblot analysis using antibodies against SMN 
and Gemin3 revealed that both proteins were phosphorylated as 
indicated by populations of more acidic forms of the proteins 
(Fig. 8 D). Strikingly, for both SMN and Gemin3, more acidic 
forms accumulated upon knockdown of PPM1G. Despite the 
overall reduction of SMN and Gemin3, relative levels of the 
less acidic forms of SMN (sector 2) were  3.5-fold decreased, 
whereas the relative levels of the more acidic forms (sector 1) 
were increased (Fig. 8 D). Similarly, more acidic forms of Gemin3 
in sector 1 were increased approximately threefold (Fig. 8 D).
Collectively, this strongly suggested that PPM1G directly dephos-
phorylates SMN-complex proteins in the nucleus.
Unrip, a cytoplasmic component of the 
SMN complex, works antagonistically 
to PPM1G
Unrip associates with the SMN complex primarily in the cyto-
plasm, and knockdown of unrip leads to the enhanced accumula-
tion of the SMN complex in CBs in the nucleus (Carissimi et al., 
2005; Grimmler et al., 2005b). This raised the possibility that 
Figure 7.  Expression of wt, but not that of catalytically inactive mPPM1G, can rescue correct nuclear localization of the SMN complex in CBs. HeLa cells 
were ﬁ  rst transfected with siRNA oligonucleotide #1 against PPM1G mRNA or a control siRNA oligo (c). Next, cells were transfected with pCMV-HA vectors 
encoding either wt (HA-mPPM1Gwt or mwt) or phosphatase-dead (HA-mPPM1G-D493A or mD493A) mPPM1G, 12 h after the ﬁ  rst transfection. 48 h after 
the ﬁ  rst transfection, cells were ﬁ  xed and immunostained with antibodies against SMN and the HA tag of mPPM1G. (A) Representative images of cells 
showing SMN, HA, and DAPI after knockdown of endogenous PPM1G and overexpression of mPPM1G versions as indicated. Bars, 20 μm. (B) Quantiﬁ  ca-
tion of phenotypes. The relative number of cells showing localization of SMN protein in CBs is plotted. Numbers are means from three independent experi-
ments and error bars represent SD. Absolute numbers of counted cells (1/2/3 experiment): control, 104/171/197; ∆hPPM1G, 139/180/187; ∆hPPM1G + 
mwt, 67/164/160; and ∆hPPM1G + mD496A, 75/160/171.JCB • VOLUME 179 • NUMBER 3 • 2007  460
PPM1G and unrip act antagonistically on the SMN complex. 
To test this, we knocked down PPM1G, unrip alone, or both gene 
products together by siRNA treatment, and then we analyzed 
SMN localization in CBs (Fig. 9). The effi  ciencies of the single 
or double knockdown were compared with controls and quanti-
fi  ed by immunoblotting (Fig. 9 A). As published previously 
(Grimmler et al., 2005b), knockdown of unrip alone led to an 
  increase in the number of nuclear bodies in which SMN accumu-
lated (unpublished data). In addition, we observed the formation 
of cytoplasmic SMN aggregates in 10–20% of all cells (Fig. 9 B). 
Knockdown of PPM1G alone (oligo pair #1; Fig. 9, A and B, ∆P) 
led to the loss of the nuclear, CB-localized SMN signal in the 
majority of cells (Fig. 9 B, SMN signal in PPM1G-depleted 
cells). In contrast, knockdown of PPM1G and unrip together 
restored apparently normal SMN localization in CBs (Fig. 9 B). 
A similar number of cells displayed normal, punctate SMN 
staining in the nucleus (1–5 bright spots, little diffuse nucleo-
plasmic signal; Fig. 9 B) compared with untreated controls. 
Figure 8.  Substrates of PPM1G within the SMN complex. (A) Immunoprecipitated SMN complex from complete HeLa cell extracts was labeled with radio-
active γ-[
32P]ATP, and then dephosphorylated in ATP-free HeLa cell extracts immunodepleted with control rabbit IgG (∆C) or with antibodies against 
hPPM1G (∆P). An input sample (only radioactive ATP incubation) and samples after 60 min incubations in ATP-free extracts were loaded for analysis by 
autoradiography and quantitative immunoblotting. Immunoblotting signals were used to correct autoradiography for the quantiﬁ  cation shown in the graphs. 
For quantiﬁ  cation, the signal differences between input and ∆C 60 min were set as 100% difference. (B) Immunodepletion control for the extracts ∆C and 
∆P used in A. (C) Control (c) and PPM1G (∆P) siRNA knockdown HeLa cells as used for the immunoblot analysis of 2D gel patterns in D were analyzed us-
ing a phosphoserine/threonine antibody to detect changes in the overall pattern of bulk phosphorylated proteins. (D) Immunoblots of 2D gels (ﬁ  rst dimen-
sion, isoelectric focusing; second dimension, SDS-PAGE) from control and PPM1G siRNA-treated HeLa cells as in C. LiCOR scans of decorations against 
SMN and Gemin3 are shown. Note that differences caused by destabilization of SMN complex components after siRNA knockdown of PPM1G were com-
pensated by showing different exposures. Tables showing the relative intensities of signals in the corresponding image sectors are shown on the right. Note 
that the absolute reduction of SMN in sector 2 was approximately sevenfold, whereas the overall reduction of SMN protein mass was only twofold, indicat-
ing a 3.5-fold speciﬁ  c decrease in the amount of less phosphorylated forms of SMN.SMN ACCUMULATION IN CBS IS GOVERNED BY PPM1G • PETRI ET AL. 461
Interestingly, cells showing cytoplasmic SMN aggregates upon 
knockdown of unrip alone (see above) were not observed any-
more after double knockdown. However, the amount of SMN 
was reduced upon knockdown of PPM1G alone and of PPM1G 
together with unrip (Fig. 9 A, ∆U, ∆P, and ∆U∆P). Collectively, 
this suggested that unrip and PPM1G have compartment-specifi  c 
and antagonistic activities toward the SMN complex.
Discussion
The biogenesis of U snRNPs is a complicated process and re-
quires activities both in the nucleus and in the cytoplasm. Newly 
transcribed and exported U snRNAs recruit Sm proteins to 
assemble the Sm core and are subsequently hypermethylated in 
the cytoplasm. The partially assembled and modifi  ed RNPs are 
then imported into the nucleus, where additional maturation 
steps lead to the completion of mature U snRNPs (Stanek and 
Neugebauer, 2006). It is clear from several studies that the SMN 
complex acts as a key assembler of U snRNPs in the cytoplasm 
(Meister et al., 2002; Gubitz et al., 2004; Pellizzoni, 2007). 
Thus, this entity not only facilitates Sm core formation but also 
serves as a binding platform for the cap-methyltransferase 
TGS1/PIMT (Mouaikel et al., 2003) and nuclear import factors 
(Rollenhagen and Pante, 2006). In fact, it has been shown that 
the SMN complex travels into the nucleus together with the 
U snRNP (Narayanan et al., 2004; Shpargel and Matera, 2005). 
Figure 9.  SiRNA-mediated codepletion of unrip and PPM1G compensates the SMN localization phenotypes of the individual depletions. (A) Immunoblot 
on total cell lysates after knockdown of PPM1G, unrip, or both (65 h after transfection), with antibodies as indicated. The table gives relative amounts of 
proteins shown in the blot after selective knockdown of gene products as indicated, compared with RCC1 as loading control (∆P, PPM1G knockdown; ∆U, 
unrip knockdown; C-S, control for single gene knockdown; and C-D, control for double gene knockdown). No number was indicated when the amounts of 
protein were <15% different from controls. (B) Immunoﬂ  uorescence images of HeLa cells after control treatment (top), knockdown (depl.) of unrip (second 
row), PPM1G (third row), or both (bottom) using antibodies against SMN and unrip, DAPI, and merge as indicated. Bar, 20 μm.JCB • VOLUME 179 • NUMBER 3 • 2007  462
In the initial phase in the nucleus, the U snRNPs appear to stay 
associated with SMN complexes until they reach CBs. At that 
point, U snRNPs and SMN complexes are believed to dissociate. 
Whereas U snRNPs disperse in nuclear interchromatin granules 
and perichromatin fi  brils (the sites of storage and splicing, 
respectively), the SMN complex is likely to return to the cyto-
plasm, although this has not been shown directly. Hence, the 
question arises of how the different functions of the SMN complex, 
its interactions with different partners, and the dynamic equilibrium 
of its subcellular localizations are regulated. Several components 
of the SMN complex were shown to be phosphorylated, particu-
larly SMN, which displayed a compartment-specifi  c  phosphory-
lation pattern. This suggested that posttranslational modifi  cations 
could be involved in the regulation of SMN-complex functions 
(Grimmler et al., 2005a).
Here, we have shown that the nuclear phosphatase PPM1G 
specifi  cally copurifi  es with the SMN complex. We observed 
that reduction of PPM1G levels in cell-free extracts, as well as 
in living cells, led to reduced dephosphorylation of SMN and 
Gemin3. Collectively, this strongly suggests that PPM1G directly 
dephosphorylates SMN and Gemin3 in the nucleus. Moreover, 
decreased levels of PPM1G cause dramatic changes in the sub-
cellular localization of SMN as shown by RNA-interference 
studies. These studies revealed that the loss of PPM1G was 
strictly correlated with the loss of SMN accumulation in CBs. 
PPM1G knockdown caused a similar phenotype for the SMN-
interacting protein Gemin2, suggesting that accumulation of the 
whole SMN complex in CBs was affected. A partial rescue of this 
phenotype was observed when we subsequently overexpressed 
mPPM1Gwt, but not upon overexpression of a catalytically 
inactive variant. Interestingly, the loss of SMN accumulation in 
CBs was not accompanied by the accumulation of SMN in other 
nuclear bodies (i.e., gems). This might suggest that reversible 
phosphorylation controls the ability of the SMN complex to 
accumulate in nuclear bodies in general. We therefore propose 
that PPM1G phosphatase activity is needed to maintain com-
partment-specifi  c phosphorylation patterns of SMN-complex 
proteins in the nucleus, which are required for accumulation of 
the SMN complex in nuclear bodies.
It has been shown previously that accumulation of the 
SMN complex in CBs depends on the direct interaction of SMN 
and coilin (Hebert et al., 2001, 2002). Consistent with that, 
knockdown of the SMN protein inhibits targeting of other pro-
teins of the SMN complex to CBs. At the same time, however, 
it induces some fragmentation of CBs into numerous smaller 
foci likely because of compromised ongoing U snRNP biogen-
esis (Shpargel and Matera, 2005; Girard et al., 2006; Lemm 
et al., 2006). Although the complete loss of localized SMN signal 
from CBs in our experiments was not correlated with the loss of 
coilin accumulation in CBs, we still observed an increased 
number of small coilin-positive structures. Moreover, PPM1G 
knockdown in our experiments also resulted in decreased levels 
of SMN, Gemin2, and Gemin3, both in the cytoplasm and in the 
nucleus. PPM1G knockdown might therefore generate a mild 
version of the phenotype seen upon direct SMN knockdown. 
When we determined the pattern of U snRNPs using the Y12 
antibody after PPM1G knockdown, no obvious differences to 
control cells were observed (unpublished data). Also, colocal-
ization of the U2 snRNP–specifi  c factor U2B with coilin in CBs 
could readily be detected in the vast majority of PPM1G knock-
down cells in which SMN did not accumulate in CBs (unpub-
lished data). As PPM1G knockdown does not cause changes in 
the overall pattern of U snRNP localization and has only mild 
effects on coilin accumulation, this raises the possibility that 
accumulation of SMN in nuclear bodies is not required for 
U snRNP biogenesis.
In many PPM1G knockdown cells, the loss of SMN from 
CBs was accompanied by an increase in the levels of diffuse 
nucleoplasmic SMN. This suggests that deregulated SMN lo-
calization in the nucleus is not a consequence of reduced levels 
of SMN, but that it might actually cause reduced SMN levels. 
Reduced cytoplasmic SMN levels explain the reduced capacity of 
extracts from PPM1G knockdown cells in U1 snRNP assembly. 
Yet, the specifi  c activity of the SMN complex in cytosolic ex-
tracts from PPM1G knockdown cells was not affected and 
localization of U snRNPs was not changed. If PPM1G knock-
down did not affect U snRNP biogenesis, it would likely also 
not infl  uence the capacity of cells in splicing of pre-mRNAs. 
However, it had been demonstrated previously that PPM1G 
plays a role in splicing if tested in cell-free extracts from HeLa 
nuclei. Still, PPM1G seemed not to be directly essential for 
splicing in the complete system, suggesting the presence of a 
redundant activity in complete splicing extracts (Murray et al., 
1999). Consistent with that, specifi  c knockdown of PPM1G 
from a cellular system in our hands did not induce differences in 
the morphology of splicing speckles as judged by immunofl  uor-
escence with antibodies against SC35. However, we did not di-
rectly test the effi  ciency of splicing in living cells with reduced 
levels of PPM1G. It is conceivable that after PPM1G knock-
down, with time, general splicing defects become apparent or 
that splicing of a certain subset of substrates is immediately im-
paired, as has now been shown for alternative splicing of the 
CD44 pre-mRNA (Allemand et al., 2007).
Our results on changed phosphorylation patterns of SMN 
components implicate the existence of a kinase, which phos-
phorylates proteins of the SMN complex. Like unrip, this kinase 
is supposedly a cytoplasmic interaction partner of the SMN com-
plex, which is spatially separated from the activity of PPM1G. 
To date, such an activity has not been identifi  ed. However, we 
showed that delocalization of SMN from CBs upon knockdown 
of PPM1G was compensated upon concomitant knockdown 
of unrip. Conversely, generations of additional SMN-positive 
aggregates in the nucleus and in the cytoplasm seen upon unrip 
knockdown were not observed when PPM1G was knocked down 
in parallel. Given an antagonistic subcellular localization of 
unrip and PPM1G, this not only indicates that proteins of the 
SMN complex can exchange between the nucleus and the cyto-
plasm, but it might also suggest that unrip is involved in cyto-
plasmic SMN phosphorylation.
Previously, PPM1G has been reported to regulate diverse 
nuclear functions in splicing (Murray et al., 1999; Allemand 
et al., 2007), histone maturation (Kimura et al., 2006), and cell 
cycle progression (Guthridge et al., 1997; Suh et al., 2006). Our 
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of the SMN complex in the nucleus and is an important regula-
tor of the subcellular localization of SMN-complex proteins. 
Many steps in SMN localization and dynamics demand regula-
tion, such as timing of import and export of components, inter-
actions with binding partners in the specifi  c subcellular domains, 
and time of residence in a particular compartment.
We consider dephosphorylation in the nucleus likely to 
follow import of the SMN complex into the nucleus to precede 
nuclear accumulation and targeting to CBs, dissociation from 
U snRNPs, and potentially retransport to the cytoplasm. It will be 
interesting in the future to determine if the dephosphorylation 
of SMN-complex proteins mediates effi  ciency, order, and tim-
ing of these events.
Materials and methods
PPM1G expression constructs
His-hPPM1G and His-xPPM1G were cloned into pQE32 (SphI–KpnI; QIA-
GEN). A PCR template for hPPM1G constructs, clone FLEXO833D0920D 
(RZPD), was used. His-xPPM1G was ampliﬁ  ed by PCR from complete cDNA 
of X. laevis eggs. His-hPPM1G D496A was generated by site-directed muta-
genesis. EYFP-hPPM1G was generated by PCR and cloned into a mono-
meric pEYFP-C1 vector (BglII–KpnI; gift from J. Ellenberg, European Molecular 
Biology Laboratory, Heidelberg, Germany). EYFP-hPPM1G-NLS was gener-
ated by cutting the EYFP-hPPM1G full-length construct with BglII and SacI 
and cloning into the corresponding sites of the same vector. For the HA-
mPPM1G construct, mPPM1G was ampliﬁ  ed from IRAKp961L079Q (RZPD) 
and cloned into the pCMV-HA vector (SalI–BglII; CLONTECH Laboratories, 
Inc.). HA-mPPM1G D493A was generated using site-directed mutagenesis.
Protein expression and puriﬁ  cation
PPM1G fusion proteins were expressed in Escherichia coli BL21 pRep4 
(QIAGEN) at 37°C and puriﬁ  ed via Ni
2+-NTA (QIAGEN) in 20 mM Hepes, 
pH 7.5, 500 mM KCl, 8 mM imidazole, 5% glycerol, 2 mM MgCl2, and 
protease inhibitor mix (1 μg/ml of pepstatin A, aprotinin, and leupeptin 
[PPM1G buffer]). Bound proteins were eluted in PPM1G buffer containing 
an additional 250 mM imidazole and further puriﬁ  ed on a poly-Lysine col-
umn (bound in PPM1G buffer with 650 mM KCl and eluted with increasing 
KCl concentrations). Puriﬁ   ed PPM1G was dialyzed to 100 mM KCl in 
PPM1G buffer (without imidazol and protease inhibitors).
Generation of antibodies against xPPM1G and hPPM1G and Gemin2
Rabbits were immunized using puriﬁ  ed 6× histidine-tagged xPPM1G or 
hPPM1G. Antibodies were afﬁ  nity puriﬁ  ed via matrix-coupled (Afﬁ  -Gel; Bio-
Rad Laboratories) antigens. Antibodies against Gemin2 were raised in 
rabbit against full-length 6× histidine-tagged human Gemin2 protein, afﬁ  n-
ity puriﬁ  ed using the respective GST-tagged antigen, and covalently linked 
to a glutathione-Sepharose matrix (GE Healthcare).
siRNA treatments
Final oligonucleotide concentration was 75 nM in all experiments except 
those shown in Fig. 9. Here, ﬁ  nal oligonucleotide concentration was 50 nM 
for oligonucleotides against each target, unrip and PPM1G mRNA. siRNA 
oligonucleotides were transfected with a mixture of RNA oligonucle-
otides and Lipofectamine 2000 (Invitrogen) in opti-MEM (1 μl Lipofectamine 
to 0.8 μg RNA).
The following double-stranded RNA oligonucleotides against human 
mRNA sequences were used: control, agacgcauugucaacauccugucug 
(vimentin; Invitrogen); PPM1G #1, ucacauuccagaugccaucacaggc (Invit-
rogen); #2, uuaaagagcuggcacagaudtdt (Dharmacon); and #3, aggcu-
accaugacuauugadtdt (Dharmacon). Against unrip, a 1:1 mixture of two 
oligonucleotides was used (Grimmler et al., 2005b).
Oligonucleotide #1, which mismatches with the mRNA of mPPM1G 
in the positions indicated in bold in the sequence above, was used for 
RNAi rescue experiments. Cells were transfected with siRNAs as described 
above. 12 h later, the medium was exchanged and cells were transfected 
a second time with pCMV-HA plasmids as described above.
Immunoﬂ  uorescence and image acquisition
HeLa CCL2 (American Type Culture Collection) and X. laevis XL177 cells 
were used for immunoﬂ  uorescence experiments. Cells on glass coverslips 
were washed and ﬁ  xed with 3% paraformaldehyde. The following primary 
antibodies were used: monoclonal SMN antibody (clone 7B10; Meister 
et al., 2001a); afﬁ  nity-puriﬁ  ed polyclonal Gemin2 antibody (this study); afﬁ  nity-
puriﬁ  ed polyclonal coilin antibody (a gift from M. Platani, European 
Molecular Biology Laboratory; Bohmann et al., 1995); polyclonal afﬁ  nity-
puriﬁ  ed anti-HA tag antibody (ab9110; Abcam); polyclonal afﬁ  nity-puriﬁ  ed 
anti-GFP antibody (a gift from D. Görlich, Zentrum für Molekulare Biologie, 
Heidelberg, Germany); polyclonal afﬁ  nity-puriﬁ  ed antibodies against xPPM1G 
and hPPM1G (this study); polyclonal antibody against unrip (Grimmler 
et al., 2005b); monoclonal antibody against SC35 (Novus Biologicals, 
Inc.); monoclonal antibody against coilin (5P10; gift from K. Neugebauer, 
Max Planck Institute of Cell Biology and Genetics, Dresden, Germany; 
Almeida et al., 1998); and a monoclonal antibody against Sm proteins 
(Y12; gift from I. Mattaj, European Molecular Biology Laboratory).
Alexa Fluor 488 goat anti–rabbit antibody (Invitrogen), Cy2 or 
Cy3 goat anti–rabbit antibody (Jackson ImmunoResearch Laboratories), 
and Cy2 or Cy3 goat anti–mouse antibody (Jackson ImmunoResearch 
Laboratories) were used as secondary antibodies together with DAPI. 
Coverslips were mounted using Fluoromount-G (Southern Biotechnology 
Associates, Inc.).
Images were acquired on ﬁ  xed samples at room temperature with a 
laser scanning confocal microscope (TCS SP2 or SP5; Leica) using 63× 
objectives (1.2, water immersion; or 1.4, oil immersion). Images were re-
corded using confocal software (Leica) and were exported as TIFF. Figures 
were then generated using Photoshop 7.0 and Illustrator CS2 (Adobe).
Immunoblotting
Samples were separated by SDS gel electrophoresis (Laemmli, 1970) and 
transferred to nitrocellulose membranes. The following primary antibodies 
were used: against PPM1G, SMN, and Gemin2 as described for immuno-
ﬂ   uorescence, monoclonal Gemin3 antibody from rat (a gift from F.A. 
Grässer, Uniklinik, Homburg/Saar, Germany), anti-RCC1 sera from rabbit 
(Hetzer et al., 2000), afﬁ  nity-puriﬁ  ed anti-snurportin antibody from rabbit 
(Paraskeva et al., 1999), and monoclonal anti-Histidine antibody (clone 
HIS-1; Sigma-Aldrich).
Alexa Fluor 680 goat anti–rabbit IgG (Invitrogen) and IRDye 800 
anti–mouse IgG (Rockland Immunochemicals, Inc.) were used as second-
ary antibodies. Fluorescence signals from immunoblots were detected and 
quantiﬁ  ed using an infrared scanner (LI-COR; Odyssey). Anti-xPPM1G 
(Fig. 1 A) was detected with horseradish peroxidase–coupled anti–rabbit 
antibody (Sigma-Aldrich). Gemin3 antibody from rat was detected with 
horseradish peroxidase–coupled anti–rat antibody (Sigma-Aldrich), and 
secondary antibody signals were detected using ECL reagent (Pierce 
Chemical Co.). For quantiﬁ   cation of Gemin3 signals, Advanced Image 
Data Analyzer software (Raytest) was used.
In vitro dephosphorylation of 𝗄-[
32P]ATP–labeled SMN complex
HeLa cells were lysed in 20 mM Hepes, pH 7.5, 500 mM KCl, 8.7% 
glycerol, 2 mM MgCl2, 1% NP-40, and protease inhibitor mix (1 μg/ml 
of pepstatin A, aprotinin, and leupeptin) by dounce homogenization.
The lysate was precleared by centrifugation in a rotor (SS34; Sor-
vall) at 16,000 rpm for 30 min and dialyzed against the same buffer as 
was used for cell lysis but without NP-40 and with 100 mM KCl. After dial-
ysis, the extract was cleared by centrifugation in a rotor (TLA 100.3; 
Beckman Coulter) at 40,000 rpm for 30 min. Part of the extract was immuno-
depleted using either rabbit control IgGs (Sigma-Aldrich) or afﬁ  nity-puriﬁ  ed 
anti-PPM1G antibody (this study).
For immunoprecipitation of the SMN complex, complete extract was 
incubated with anti-SMN (7B10) antibody prebound to protein G Dyna-
beads (Invitrogen). Beads were washed with buffer, as for dialysis of ex-
tract, but containing 0.01% Triton X-100 and 200 mM KCl. Beads were 
incubated at 32°C for 30 min in extract supplied with a mixture of cold and 
γ-[
32P]ATP, washed again, divided, and incubated in control-depleted 
extract or PPM1G-depleted extract without ATP at 32°C for 60 min. Beads 
were washed with buffer as for dialysis of extract, but containing 5 mM 
EDTA instead of MgCl2 and incubated in SDS-PAGE sample buffer. Sam-
ples were analyzed by immunoblotting and autoradiography.
2D gel immunoblotting analysis of whole cell lysates from HeLa cells
After siRNA treatment, cell pellets were resuspended in isoelectric focusing 
buffer containing 6 M urea, 2 M thiourea, 2% CHAPS, 0.15% DTT, and 
0.5% ampholytes (Pharmalytes; GE Healthcare). In this buffer, cells were 
soniﬁ  ed and centrifuged in a rotor (TLA 100.3) for 30 min at 40,000 rpm. 
Supernatant was used for isoelectric focusing with Immobiline Dry Strips, pH 
3–10 (nonlinear; GE Healthcare), followed by SDS-PAGE and immunoblot.JCB • VOLUME 179 • NUMBER 3 • 2007  464
Calculation of PPM1G concentration in nuclei of X. laevis oocytes and 
HeLa cells
Immunoblotting of dilution series of recombinant-puriﬁ   ed xPPM1G and 
hPPM1G compared with complete X. laevis oocyte extract or complete 
HeLa lysates was used to estimate PPM1G concentrations to be 700 nM in 
X. laevis oocytes, 5 μM in X. laevis oocyte nuclei, 300 nM in HeLa, and at 
least 1 μM in HeLa nuclei.
Transfection of cells with plasmids
Approximately 2 × 10
5 HeLa CCL2 cells were transfected with a mixture 
of 0.7 μg DNA and 1.4 μl Lipofectamine 2000 (Invitrogen) in OPTI-MEM 
medium (Invitrogen) according to the manufacturer’s protocol.
HeLa cell extract, fractionation, immunoprecipitation, and protein–protein 
interaction assay
HeLa S3 cells were resuspended in 2.5 vol PBS containing 0.01% IgePal 
(Rhodia Inc.), lyzed by sonication, and cleared by centrifugation (SW 32 
Ti; Beckman Coulter) for 10 min at 10,000 rpm. The supernatant (cell 
extract) was passed through a 0.2-μm low-protein–binding ﬁ  lter.
Immunoprecipitations were performed with 7B10 monoclonal anti-
SMN antibody (Meister et al., 2001a) or normal mouse serum covalently 
linked to protein G–Sepharose. After washing, immunoprecipitated pro-
teins were eluted by boiling in 2× SDS sample buffer.
The protein–protein interaction assay consisted of the following: 
immunoprecipitated SMN complex from HeLa cell extract was incubated 
with 5 μg of recombinant hPPM1G in 50 μl of buffer containing 20 mM 
Hepes, 100 mM KCl, 5 mM MgCl2, 2 mM MnCl2, and 2% glycerol, pH 7.5. 
After washing, interacting proteins were eluted from the Sepharose matrix 
by boiling in 2× SDS sample buffer.
The Qproteome nuclear protein kit (QIAGEN) was used to separate 
nuclei and cytosols according to the manufacturer’s protocol. Cytoplasmic 
supernatants were precipitated in 80% −20°C acetone, and isolated nu-
clei were directly lyzed in 1.5× SDS gel sample buffer.
Online supplemental material
Fig. S1 shows that expression of EYFP-PPM1G without NLS sequence (EYFP-
PPM1G-NLS), but not expression of PPM1Gwt (EYFP-PPM1G), changes lo-
calization of the SMN complex in HeLa cells. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200704163/DC1.
We thank Melpi Platani, Karla Neugebauer, Dirk Görlich, and Iain Mattaj for 
antibodies, Jan Ellenberg for the EYFP fusion vector, Markus T. Bohnsack for 
help with oocyte dissections, and Kerstin Hupfeld for excellent technical assis-
tance. We are grateful to Hartmut Krischke and Thomas Ruppert for support 
with 2D gel electrophoresis.
This work was supported by the Zentrum für Molekulare Biologie and 
the Deutsche Forschungsgemeinschaft (GR1737/4-1/2 to O.J. Gruss and 
FI573/4-1 and SFB581 to U. Fischer).
Submitted: 26 April 2007
Accepted: 3 October 2007
References
Allemand, E., M.L. Hastings, M.V. Murray, M.P. Myers, and A.R. Krainer. 
2007. Alternative splicing regulation by interaction of phosphatase 
PP2Cgamma with nucleic acid-binding protein YB-1. Nat. Struct. Mol. 
Biol. 14:630–638.
Almeida, F., R. Saffrich, W. Ansorge, and M. Carmo-Fonseca. 1998. Micro-
injection of anti-coilin antibodies affects the structure of coiled bodies. 
J. Cell Biol. 142:899–912.
Bohmann, K., J. Ferreira, N. Santama, K. Weis, and A.I. Lamond. 1995. 
Molecular analysis of the coiled body. J. Cell Sci. Suppl. 19:107–113.
Brahms, H., L. Meheus, V. de Brabandere, U. Fischer, and R. Luhrmann. 2001. 
Symmetrical dimethylation of arginine residues in spliceosomal Sm pro-
tein B/B’ and the Sm-like protein LSm4, and their interaction with the 
SMN protein. RNA. 7:1531–1542.
Carissimi, C., J. Baccon, M. Straccia, P. Chiarella, A. Maiolica, A. Sawyer, J. 
Rappsilber, and L. Pellizzoni. 2005. Unrip is a component of SMN com-
plexes active in snRNP assembly. FEBS Lett. 579:2348–2354.
Carvalho, T., F. Almeida, A. Calapez, M. Lafarga, M.T. Berciano, and M. Carmo-
Fonseca. 1999. The spinal muscular atrophy disease gene product, SMN: 
a link between snRNP biogenesis and the Cajal (coiled) body. J. Cell 
Biol. 147:715–728.
Dundr, M., M.D. Hebert, T.S. Karpova, D. Stanek, H. Xu, K.B. Shpargel, U.T. 
Meier, K.M. Neugebauer, A.G. Matera, and T. Misteli. 2004. In vivo 
kinetics of Cajal body components. J. Cell Biol. 164:831–842.
Friesen, W.J., S. Massenet, S. Paushkin, A. Wyce, and G. Dreyfuss. 2001. SMN, 
the product of the spinal muscular atrophy gene, binds preferentially to 
dimethylarginine-containing protein targets. Mol. Cell. 7:1111–1117.
Girard, C., H. Neel, E. Bertrand, and R. Bordonne. 2006. Depletion of SMN by 
RNA interference in HeLa cells induces defects in Cajal body formation. 
Nucleic Acids Res. 34:2925–2932.
Grimmler, M., L. Bauer, M. Nousiainen, R. Korner, G. Meister, and U. Fischer. 
2005a. Phosphorylation regulates the activity of the SMN complex during 
assembly of spliceosomal U snRNPs. EMBO Rep. 6:70–76.
Grimmler, M., S. Otter, C. Peter, F. Muller, A. Chari, and U. Fischer. 2005b. 
Unrip, a factor implicated in cap-independent translation, associates with 
the cytosolic SMN complex and infl  uences its intracellular localization. 
Hum. Mol. Genet. 14:3099–3111.
Gubitz, A.K., W. Feng, and G. Dreyfuss. 2004. The SMN complex. Exp. Cell 
Res. 296:51–56.
Guthridge, M.A., P. Bellosta, N. Tavoloni, and C. Basilico. 1997. FIN13, a novel 
growth factor-inducible serine-threonine phosphatase which can inhibit 
cell cycle progression. Mol. Cell. Biol. 17:5485–5498.
Hamm, J., E. Darzynkiewicz, S.M. Tahara, and I.W. Mattaj. 1990. The trimethyl-
guanosine cap structure of U1 snRNA is a component of a bipartite 
nuclear targeting signal. Cell. 62:569–577.
Hebert, M.D., P.W. Szymczyk, K.B. Shpargel, and A.G. Matera. 2001. Coilin 
forms the bridge between Cajal bodies and SMN, the spinal muscular 
atrophy protein. Genes Dev. 15:2720–2729.
Hebert, M.D., K.B. Shpargel, J.K. Ospina, K.E. Tucker, and A.G. Matera. 
2002. Coilin methylation regulates nuclear body formation. Dev. Cell. 
3:329–337.
Hetzer, M., D. Bilbao-Cortes, T.C. Walther, O.J. Gruss, and I.W. Mattaj. 2000. 
GTP hydrolysis by Ran is required for nuclear envelope assembly. Mol. 
Cell. 5:1013–1024.
Kimura, H., N. Takizawa, E. Allemand, T. Hori, F.J. Iborra, N. Nozaki, M. Muraki, 
M. Hagiwara, A.R. Krainer, T. Fukagawa, and K. Okawa. 2006. A novel 
histone exchange factor, protein phosphatase 2Cγ, mediates the exchange 
and dephosphorylation of H2A–H2B. J. Cell Biol. 175:389–400.
Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the 
head of bacteriophage T4. Nature. 227:680–685.
Lemm, I., C. Girard, A.N. Kuhn, N.J. Watkins, M. Schneider, R. Bordonne, and 
R. Luhrmann. 2006. Ongoing U snRNP biogenesis is required for the 
integrity of Cajal bodies. Mol. Biol. Cell. 17:3221–3231.
Liu, Q., and G. Dreyfuss. 1996. A novel nuclear structure containing the survival 
of motor neurons protein. EMBO J. 15:3555–3565.
Matera, A.G., R.M. Terns, and M.P. Terns. 2007. Non-coding RNAs: lessons 
from the small nuclear and small nucleolar RNAs. Nat. Rev. Mol. Cell 
Biol. 8:209–220.
Meister, G., and U. Fischer. 2002. Assisted RNP assembly: SMN and PRMT5 
complexes cooperate in the formation of spliceosomal UsnRNPs. EMBO J. 
21:5853–5863.
Meister, G., D. Buhler, R. Pillai, F. Lottspeich, and U. Fischer. 2001a. A multi-
protein complex mediates the ATP-dependent assembly of spliceosomal 
U snRNPs. Nat. Cell Biol. 3:945–949.
Meister, G., C. Eggert, D. Buhler, H. Brahms, C. Kambach, and U. Fischer. 
2001b. Methylation of Sm proteins by a complex containing PRMT5 and 
the putative U snRNP assembly factor pICln. Curr. Biol. 11:1990–1994.
Meister, G., C. Eggert, and U. Fischer. 2002. SMN-mediated assembly of RNPs: 
a complex story. Trends Cell Biol. 12:472–478.
Mouaikel, J., U. Narayanan, C. Verheggen, A.G. Matera, E. Bertrand, J. Tazi, 
and R. Bordonne. 2003. Interaction between the small-nuclear-RNA 
cap hypermethylase and the spinal muscular atrophy protein, survival of 
motor neuron. EMBO Rep. 4:616–622.
Murray, M.V., R. Kobayashi, and A.R. Krainer. 1999. The type 2C Ser/Thr 
phosphatase PP2Cgamma is a pre-mRNA splicing factor. Genes Dev. 
13:87–97.
Narayanan, U., T. Achsel, R. Luhrmann, and A.G. Matera. 2004. Coupled in 
vitro import of U snRNPs and SMN, the spinal muscular atrophy protein. 
Mol. Cell. 16:223–234.
Nilsen, T.W. 2003. The spliceosome: the most complex macromolecular machine 
in the cell? Bioessays. 25:1147–1149.
O’Keefe, R.T., A. Mayeda, C.L. Sadowski, A.R. Krainer, and D.L. Spector. 
1994. Disruption of pre-mRNA splicing in vivo results in reorganization 
of splicing factors. J. Cell Biol. 124:249–260.
Paraskeva, E., E. Izaurralde, F.R. Bischoff, J. Huber, U. Kutay, E. Hartmann, R. 
Luhrmann, and D. Gorlich. 1999. CRM1-mediated recycling of snurportin 1 
to the cytoplasm. J. Cell Biol. 145:255–264.SMN ACCUMULATION IN CBS IS GOVERNED BY PPM1G • PETRI ET AL. 465
Pellizzoni, L. 2007. Chaperoning ribonucleoprotein biogenesis in health and disease. 
EMBO Rep. 8:340–345.
Raker, V.A., G. Plessel, and R. Luhrmann. 1996. The snRNP core assembly path-
way: identifi  cation of stable core protein heteromeric complexes and an 
snRNP subcore particle in vitro. EMBO J. 15:2256–2269.
Rollenhagen, C., and N. Pante. 2006. Nuclear import of spliceosomal snRNPs. 
Can. J. Physiol. Pharmacol. 84:367–376.
Shpargel, K.B., and A.G. Matera. 2005. Gemin proteins are required for effi  cient 
assembly of Sm-class ribonucleoproteins. Proc. Natl. Acad. Sci. USA. 
102:17372–17377.
Stanek, D., and K.M. Neugebauer. 2006. The Cajal body: a meeting place for 
spliceosomal snRNPs in the nuclear maze. Chromosoma. 115:343–354.
Suh, E.J., T.Y. Kim, and S.H. Kim. 2006. PP2Cgamma-mediated S-phase 
accumulation induced by the proteasome-dependent degradation of 
p21(WAF1/CIP1). FEBS Lett. 580:6100–6104.